Varghese S - Search Results

1

Systemic therapy of spontaneous prostate cancer in transgenic mice with oncolytic herpes simplex viruses.

Varghese S, Rabkin SD, Nielsen GP, MacGarvey U, Liu R, Martuza RL. Varghese S, et al. Cancer Res. 2007 Oct 1;67(19):9371-9. doi: 10.1158/0008-5472.CAN-07-0674. Cancer Res. 2007. PMID: 17909046

2

Preclinical safety evaluation of G207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primates.

Varghese S, Newsome JT, Rabkin SD, McGeagh K, Mahoney D, Nielsen P, Todo T, Martuza RL. Varghese S, et al. Hum Gene Ther. 2001 May 20;12(8):999-1010. doi: 10.1089/104303401750195944. Hum Gene Ther. 2001. PMID: 11387063

3

Ionizing radiation does not alter the antitumor activity of herpes simplex virus vector G207 in subcutaneous tumor models of human and murine prostate cancer.

Jorgensen TJ, Katz S, Wittmack EK, Varghese S, Todo T, Rabkin SD, Martuza RL. Jorgensen TJ, et al. Among authors: varghese s. Neoplasia. 2001 Sep-Oct;3(5):451-6. doi: 10.1038/sj.neo.7900193. Neoplasia. 2001. PMID: 11687957 Free PMC article.

4

Oncolytic herpes simplex virus vectors for cancer virotherapy.

Varghese S, Rabkin SD. Varghese S, et al. Cancer Gene Ther. 2002 Dec;9(12):967-78. doi: 10.1038/sj.cgt.7700537. Cancer Gene Ther. 2002. PMID: 12522436 Review.

5

Oncolytic herpes simplex virus vector therapy of breast cancer in C3(1)/SV40 T-antigen transgenic mice.

Liu R, Varghese S, Rabkin SD. Liu R, et al. Among authors: varghese s. Cancer Res. 2005 Feb 15;65(4):1532-40. doi: 10.1158/0008-5472.CAN-04-3353. Cancer Res. 2005. PMID: 15735042

6

Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers.

Varghese S, Rabkin SD, Liu R, Nielsen PG, Ipe T, Martuza RL. Varghese S, et al. Cancer Gene Ther. 2006 Mar;13(3):253-65. doi: 10.1038/sj.cgt.7700900. Cancer Gene Ther. 2006. PMID: 16179929

7

Systemic oncolytic herpes virus therapy of poorly immunogenic prostate cancer metastatic to lung.

Varghese S, Rabkin SD, Nielsen PG, Wang W, Martuza RL. Varghese S, et al. Clin Cancer Res. 2006 May 1;12(9):2919-27. doi: 10.1158/1078-0432.CCR-05-1187. Clin Cancer Res. 2006. PMID: 16675589

8

Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells.

Passer BJ, Castelo-Branco P, Buhrman JS, Varghese S, Rabkin SD, Martuza RL. Passer BJ, et al. Among authors: varghese s. Cancer Gene Ther. 2009 Jul;16(7):551-60. doi: 10.1038/cgt.2009.10. Epub 2009 Feb 6. Cancer Gene Ther. 2009. PMID: 19197321 Free PMC article.

9

Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.

Hong L, Aminu M, Li S, Lu X, Petranovic M, Saad MB, Chen P, Qin K, Varghese S, Rinsurongkawong W, Rinsurongkawong V, Spelman A, Elamin YY, Negrao MV, Skoulidis F, Gay CM, Cascone T, Gandhi SJ, Lin SH, Lee PP, Carter BW, Wu CC, Antonoff MB, Sepesi B, Lewis J, Gibbons DL, Vaporciyan AA, Le X, Jack Lee J, Roy-Chowdhuri S, Routbort MJ, Gainor JF, Heymach JV, Lou Y, Wu J, Zhang J, Vokes NI. Hong L, et al. Among authors: varghese s. Nat Commun. 2023 Feb 8;14(1):695. doi: 10.1038/s41467-023-36328-z. Nat Commun. 2023. PMID: 36755027 Free PMC article.

10

Rat thymosin beta 4 gene. Intron-containing gene and multiple retroposons.

Varghese S, Kronenberg HM. Varghese S, et al. J Biol Chem. 1991 Aug 5;266(22):14256-61. J Biol Chem. 1991. PMID: 1650352 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

930 results

Search Page

Filters